IRIS Accounts Production v26.2.0.496 08821167 Board of Directors 1.1.25 31.12.25 31.12.25 0 0 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh088211672024-12-31088211672025-12-31088211672025-01-012025-12-31088211672023-12-31088211672024-01-012024-12-31088211672024-12-3108821167ns15:EnglandWales2025-01-012025-12-3108821167ns14:PoundSterling2025-01-012025-12-3108821167ns10:Director12025-01-012025-12-3108821167ns10:PrivateLimitedCompanyLtd2025-01-012025-12-3108821167ns10:SmallEntities2025-01-012025-12-3108821167ns10:AuditExempt-NoAccountantsReport2025-01-012025-12-3108821167ns10:SmallCompaniesRegimeForDirectorsReport2025-01-012025-12-3108821167ns10:SmallCompaniesRegimeForAccounts2025-01-012025-12-3108821167ns10:FullAccounts2025-01-012025-12-3108821167ns5:CurrentFinancialInstruments2025-12-3108821167ns5:CurrentFinancialInstruments2024-12-3108821167ns5:ShareCapital2025-12-3108821167ns5:ShareCapital2024-12-3108821167ns5:RetainedEarningsAccumulatedLosses2025-12-3108821167ns5:RetainedEarningsAccumulatedLosses2024-12-3108821167ns5:PlantMachinery2024-12-3108821167ns5:PlantMachinery2025-01-012025-12-3108821167ns5:PlantMachinery2025-12-3108821167ns5:PlantMachinery2024-12-3108821167ns5:CostValuation2024-12-3108821167ns5:AdditionsToInvestments2025-12-3108821167ns5:DisposalsRepaymentsInvestments2025-12-3108821167ns5:RevaluationsIncreaseDecreaseInInvestments2025-12-3108821167ns5:CostValuation2025-12-3108821167ns5:WithinOneYearns5:CurrentFinancialInstruments2025-12-3108821167ns5:WithinOneYearns5:CurrentFinancialInstruments2024-12-3108821167ns5:AfterOneYearns5:Non-currentFinancialInstruments2025-12-3108821167ns5:AfterOneYearns5:Non-currentFinancialInstruments2024-12-3108821167ns10:Director22025-01-012025-12-31088211672ns10:Director22024-12-31088211672ns10:Director22023-12-31088211672ns10:Director22025-01-012025-12-31088211672ns10:Director22024-01-012024-12-31088211672ns10:Director22025-12-31088211672ns10:Director22024-12-3108821167ns10:Director112024-12-3108821167ns10:Director112023-12-3108821167ns10:Director112025-01-012025-12-3108821167ns10:Director112024-01-012024-12-3108821167ns10:Director112025-12-3108821167ns10:Director112024-12-3108821167ns10:Director32025-01-012025-12-3108821167ns10:Director332024-12-3108821167ns10:Director332023-12-3108821167ns10:Director332025-01-012025-12-3108821167ns10:Director332024-01-012024-12-3108821167ns10:Director332025-12-3108821167ns10:Director332024-12-31
REGISTERED NUMBER: 08821167 (England and Wales)



















Unaudited Financial Statements

for the Year Ended 31 December 2025

for

CLAREMONT ANAESTHETISTS LIMITED

CLAREMONT ANAESTHETISTS LIMITED (REGISTERED NUMBER: 08821167)






Contents of the Financial Statements
for the Year Ended 31 December 2025




Page

Balance Sheet 1

Notes to the Financial Statements 3


CLAREMONT ANAESTHETISTS LIMITED (REGISTERED NUMBER: 08821167)

Balance Sheet
31 December 2025

2025 2024
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 3 47,299 34,537
Investments 4 847,009 476,371
894,308 510,908

CURRENT ASSETS
Debtors 5 451,097 458,379
Cash at bank 210,852 276,534
661,949 734,913
CREDITORS
Amounts falling due within one year 6 94,334 89,967
NET CURRENT ASSETS 567,615 644,946
TOTAL ASSETS LESS CURRENT
LIABILITIES

1,461,923

1,155,854

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 1,461,823 1,155,754
SHAREHOLDERS' FUNDS 1,461,923 1,155,854

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

CLAREMONT ANAESTHETISTS LIMITED (REGISTERED NUMBER: 08821167)

Balance Sheet - continued
31 December 2025


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 1 September 2026 and were signed on its behalf by:





Navneet Kumar Narula - Director


CLAREMONT ANAESTHETISTS LIMITED (REGISTERED NUMBER: 08821167)

Notes to the Financial Statements
for the Year Ended 31 December 2025

1. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

2. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2024 - NIL).

CLAREMONT ANAESTHETISTS LIMITED (REGISTERED NUMBER: 08821167)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2025

3. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 January 2025 67,886
Additions 27,354
At 31 December 2025 95,240
DEPRECIATION
At 1 January 2025 33,349
Charge for year 14,592
At 31 December 2025 47,941
NET BOOK VALUE
At 31 December 2025 47,299
At 31 December 2024 34,537

4. FIXED ASSET INVESTMENTS
Other
investments
£   
COST OR VALUATION
At 1 January 2025 476,371
Additions 480,000
Disposals (187,576 )
Share of profit/(loss) 2,902
Revaluations 75,312
At 31 December 2025 847,009
NET BOOK VALUE
At 31 December 2025 847,009
At 31 December 2024 476,371

Cost or valuation at 31 December 2025 is represented by:

Other
investments
£   
Cost 847,009

CLAREMONT ANAESTHETISTS LIMITED (REGISTERED NUMBER: 08821167)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2025

5. DEBTORS
2025 2024
£    £   
Amounts falling due within one year:
Trade debtors 406,097 403,379

Amounts falling due after more than one year:
Other debtors 45,000 55,000

Aggregate amounts 451,097 458,379

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Trade creditors 1,520 2,580
Taxation and social security 84,420 57,348
Other creditors 8,394 30,039
94,334 89,967

7. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 31 December 2025 and 31 December 2024:

2025 2024
£    £   
Ashu Loona
Balance outstanding at start of year (10,013 ) (432 )
Amounts advanced 10,380 323
Amounts repaid (3,165 ) (9,904 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (2,798 ) (10,013 )

Navneet Kumar Narula
Balance outstanding at start of year (10,013 ) (432 )
Amounts advanced 10,380 323
Amounts repaid (3,165 ) (9,904 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (2,798 ) (10,013 )

CLAREMONT ANAESTHETISTS LIMITED (REGISTERED NUMBER: 08821167)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2025

7. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES - continued

Arjun Narula
Balance outstanding at start of year (10,013 ) (432 )
Amounts advanced 10,379 323
Amounts repaid (3,164 ) (9,904 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (2,798 ) (10,013 )

Dividends issued during the year is Nil (Nil in 2024)

8. RELATED PARTY DISCLOSURES

Amount due from Inter Co - Loona Solutions Ltd is £18,000 (£18,000 in 2024)
Amount due from Inter Co - Loona Holdings Ltd is £381,878 (£381878 in 2024)